Current management of the Rh-sensitized patient.
D000649:Amniocentesis; D000653:Amniotic Fluid / Q000032:analysis; D001663:Bilirubin / Q000032:analysis; D001787:Blood Group Incompatibility / Q000097:blood / Q000628:therapy*; D004899:Erythroblastosis, Fetal / Q000517:prevention & control; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis; D005333:Fetus / Q000033:anatomy & histology; D005865:Gestational Age; D006801:Humans; D007518:Isoantibodies / Q000032:analysis; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System / Q000276:immunology* / Q000627:therapeutic use*; D018029:Rho(D) Immune Globulin; D014463:Ultrasonography; D005719:gamma-Globulins / Q000627:therapeutic use*
D007518:Isoantibodies; D012204:Rh-Hr Blood-Group System; D018029:Rho(D) Immune Globulin; D005719:gamma-Globulins; D001663:Bilirubin